Sorbonne Paris Nord University, INSERM U1153, INRAE U1125, CNAM, Nutritional Epidemiology Research Team (EREN), Epidemiology and Statistics Research Centre, University of Paris (CRESS), Bobigny, France.
French network for Nutrition and Cancer Research (NACRe network), Jouy-en-Josas, France.
BMJ. 2022 Sep 7;378:e071204. doi: 10.1136/bmj-2022-071204.
To study the associations between artificial sweeteners from all dietary sources (beverages, but also table top sweeteners, dairy products, etc), overall and by molecule (aspartame, acesulfame potassium, and sucralose), and risk of cardiovascular diseases (overall, coronary heart disease, and cerebrovascular disease).
Population based prospective cohort study (2009-21).
France, primary prevention research.
103 388 participants of the web based NutriNet-Santé cohort (mean age 42.2±14.4, 79.8% female, 904 206 person years). Dietary intakes and consumption of artificial sweeteners were assessed by repeated 24 h dietary records, including brand names of industrial products.
Associations between sweeteners (coded as a continuous variable, log10 transformed) and cardiovascular disease risk, assessed by multivariable adjusted Cox hazard models.
Total artificial sweetener intake was associated with increased risk of cardiovascular diseases (1502 events, hazard ratio 1.09, 95% confidence interval 1.01 to 1.18, P=0.03); absolute incidence rate in higher consumers (above the sex specific median) and non-consumers was 346 and 314 per 100 000 person years, respectively. Artificial sweeteners were more particularly associated with cerebrovascular disease risk (777 events, 1.18, 1.06 to 1.31, P=0.002; incidence rates 195 and 150 per 100 000 person years in higher and non-consumers, respectively). Aspartame intake was associated with increased risk of cerebrovascular events (1.17, 1.03 to 1.33, P=0.02; incidence rates 186 and 151 per 100 000 person years in higher and non-consumers, respectively), and acesulfame potassium and sucralose were associated with increased coronary heart disease risk (730 events; acesulfame potassium: 1.40, 1.06 to 1.84, P=0.02; incidence rates 167 and 164; sucralose: 1.31, 1.00 to 1.71, P=0.05; incidence rates 271 and 161).
The findings from this large scale prospective cohort study suggest a potential direct association between higher artificial sweetener consumption (especially aspartame, acesulfame potassium, and sucralose) and increased cardiovascular disease risk. Artificial sweeteners are present in thousands of food and beverage brands worldwide, however they remain a controversial topic and are currently being re-evaluated by the European Food Safety Authority, the World Health Organization, and other health agencies.
ClinicalTrials.gov NCT03335644.
研究所有饮食来源(饮料,还有餐桌甜味剂、乳制品等)的人工甜味剂与心血管疾病(总体、冠心病和脑血管疾病)风险之间的关联,以及按分子(阿斯巴甜、乙酰磺胺酸钾和三氯蔗糖)分类的关联。
基于人群的前瞻性队列研究(2009-21 年)。
法国,初级预防研究。
NutriNet-Santé 网络队列的 103388 名参与者(平均年龄 42.2±14.4 岁,79.8%为女性,904206 人年)。人工甜味剂的摄入量和消耗情况通过重复的 24 小时饮食记录来评估,包括工业产品的品牌名称。
甜味剂(编码为连续变量,取对数 10 转换)与心血管疾病风险之间的关联,采用多变量调整的 Cox 风险模型进行评估。
总人工甜味剂摄入量与心血管疾病风险增加相关(1502 例事件,风险比 1.09,95%置信区间 1.01 至 1.18,P=0.03);高摄入量(高于性别特异性中位数)和非摄入者的绝对发病率分别为每 100000 人年 346 和 314 例。人工甜味剂与脑血管疾病风险的相关性更为显著(777 例事件,1.18,1.06 至 1.31,P=0.002;高摄入者和非摄入者的发病率分别为每 100000 人年 195 和 150 例)。阿斯巴甜摄入量与脑血管事件风险增加相关(1.17,1.03 至 1.33,P=0.02;高摄入者和非摄入者的发病率分别为每 100000 人年 186 和 151 例),乙酰磺胺酸钾和三氯蔗糖与冠心病风险增加相关(730 例事件;乙酰磺胺酸钾:1.40,1.06 至 1.84,P=0.02;发病率为 167 和 164;三氯蔗糖:1.31,1.00 至 1.71,P=0.05;发病率为 271 和 161)。
这项大规模前瞻性队列研究的结果表明,较高的人工甜味剂摄入量(特别是阿斯巴甜、乙酰磺胺酸钾和三氯蔗糖)与心血管疾病风险增加之间可能存在直接关联。人工甜味剂存在于全球数千种食品和饮料品牌中,但它们仍然是一个有争议的话题,目前正在受到欧洲食品安全局、世界卫生组织和其他卫生机构的重新评估。
ClinicalTrials.gov NCT03335644。